World Hepatitis Day July 28th

Hey everyone!  I know I know I am a couple days late, but its never too late for valuable information!

World Hepatitis Day is an international event focused on raising awareness about viral hepatitis and influencing real change in disease prevention and access to testing and treatment.

The first World Hepatitis Day was held in 2008. In July 2010, the World Health Organization endorsed July 28^th as an official global health awareness day in honor of hepatitis. The World Hepatitis Alliancecoordinates World Hepatitis Day internationally.

Today, about 500 million people worldwide – one in 12 – are living with chronic viral hepatitis B or Hepatitis C. In Canada, an estimated 600,000 people have viral hepatitis, with many unaware of their status.

We are in an exciting era with hepatitis C (HCV), with treatments that can cure over 90 per cent of people with few side effects in about three months.

However, for many people accessing the full continuum of services for their care can seem unclear and difficult. They need more information about, and a greater understanding of, access to testing services and linkage to care, including these new treatment options.

Approximately 500 million people worldwide are living with either hepatitis B or hepatitis C. If left untreated and unman-aged, hepatitis B or C can lead to advanced liver scarring (cirrhosis) and other complications, including liver cancer or liver failure. While many people worry more about contracting AIDS than hepatitis, the reality is that every year 1.5 million people worldwide die from either hepatitis B or C faster than they would from HIV/AIDS

What are the different types of hepatitis viruses occurring around the world?

The five hepatitis viruses - A, B, C, D and E - are distinct; they can have different modes of transmission, affect different populations, and result in different health outcomes. While hepatitis B and hepatitis C cause the greatest global burden of disease, hepatitis A, hepatitis D, and hepatitis E are also global health concerns.

• Hepatitis A is primarily spread when someone who has never been infected with hepatitis A and is not vaccinated, ingests food or water that is contaminated with the feces of an infected person or has direct contact with someone who is infected. Hepatitis A does not cause chronic liver disease and is rarely fatal, but it can cause serious symptoms. Hepatitis A can be prevented through improved sanitation, food safety, and vaccination.
• Hepatitis B is spread through contact with blood or other body fluids of an infected person, including at birth from a mother to her baby and through sexual contact. The hepatitis B virus can cause both acute and chronic infection, ranging in severity from a mild illness lasting a few weeks to a serious, chronic illness. People who are chronically infected can develop liver cirrhosis or even liver cancer. Hepatitis B is most common in sub-Saharan Africa and east Asia, where between 5–10% of the adult population is chronically infected. Rates of chronic hepatitis B are also high in the Amazon region of South America, the southern parts of eastern and central Europe, the Middle East and the Indian subcontinent. Many people with chronic hepatitis B were infected at birth or during early childhood. Getting the hepatitis B vaccine is the most effective way to prevent hepatitis B virus infection. WHO recommends that all infants receive the hepatitis B vaccine as soon as possible after birth. In many parts of the world, widespread infant vaccination programs have led to dramatic declines of new hepatitis B cases.  
• Hepatitis C is spread through contact with blood of an infected person. Hepatitis C is common in many countries in the world; in much of Asia and Africa, most infections are caused by unsafe medical injections and other medical procedures. Hepatitis C related to injecting drug use occurs throughout the world; an estimated 67% of people who inject drugs having been infected with the hepatitis C virus. Mother-to-child transmission of hepatitis C is also possible. Hepatitis C, like hepatitis B, can also cause both acute and chronic infections, but most people who get infected develop a chronic infection. A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer. Antiviral medicines can cure approximately 90% of people with hepatitis C, thereby reducing the risk of death from liver cancer and cirrhosis, but access to diagnosis and treatment is low. There is currently no vaccine for hepatitis C but research in this area is ongoing.
• Hepatitis D is passed through contact with infected blood. It only occurs in people who are already infected with the hepatitis B virus. People who are not already infected with hepatitis B can prevent hepatitis D by getting vaccinated against hepatitis B.
• Hepatitis E is spread mainly through contaminated drinking water. Hepatitis E usually clears in 4-6 weeks so there is no specific treatment. However, pregnant women infected with hepatitis E are at considerable risk of mortality from this infection.  Hepatitis E is found worldwide, but the number of infections is highest in East and South Asia. Improved sanitation and food safety can help prevent new cases of hepatitis E. A vaccine to prevent hepatitis E has been developed and is licensed in China, but is not yet available elsewhere.

  Do you need to be vaccinated and/or tested for hepatitis?

  CDC and DVH are continuing to lay the foundation for the elimination of viral hepatitis as a public health threat, both domestically and abroad. Hepatitis A, hepatitis B, and hepatitis C are the most common types of viral hepatitis in the United States. To see if you need to be tested and/or vaccinated for hepatitis A, B, or C, take CDC’s online Hepatitis Risk Assessment, which is based on U.S. recommendations.
• For more information:
• http://www.cdc.gov/hepatitis/worldhepdayresources.htm